OBJECTIVE: To study the prevalence of and associated factors for cognitive impairment and dementia in community dwelling Chinese from Singapore. METHODS: This study includes Chinese subjects from the Epidemiology of Dementia in Singapore (EDIS) study, aged ≥60 years, who underwent comprehensive examinations, including cognitive screening with the locally validated Abbreviated Mental Test and Progressive Forgetfulness Questionnaire. Screen positive participants subsequently underwent extensive neuropsychological testing and cerebral MRI. Cognitive impairment no dementia (CIND) and dementia were diagnosed according to internationally accepted criteria. The prevalence of cognitive impairment and dementia were computed per 5 year age categories and gender. To examine the relationship between baseline associated factors and cognitive impairment, we used logistic regression models to compute odd ratios with 95% CI. RESULTS: 1538 Chinese subjects, aged ≥60 years, underwent cognitive screening: 171 (15.2%) were diagnosed with any cognitive impairment, of whom 84 were CIND mild, 80 CIND moderate and seven had dementia. The overall age adjusted prevalence of CIND mild was 7.2%; CIND moderate/dementia was 7.9%. The prevalence increased with age, from 5.9% in those aged 60-64 years to 31.3% in those aged 75-79 years and 44.1% in those aged ≥80 years. Multivariate analysis revealed age, diabetes and hyperlipidaemia to be independently associated with cognitive impairment. CONCLUSIONS: In present study, the overall prevalence of cognitive impairment and dementia in Chinese was 15.2%, which is in the same range as the prevalence reported in Caucasian and other Asian populations.
OBJECTIVE: To study the prevalence of and associated factors for cognitive impairment and dementia in community dwelling Chinese from Singapore. METHODS: This study includes Chinese subjects from the Epidemiology of Dementia in Singapore (EDIS) study, aged ≥60 years, who underwent comprehensive examinations, including cognitive screening with the locally validated Abbreviated Mental Test and Progressive Forgetfulness Questionnaire. Screen positive participants subsequently underwent extensive neuropsychological testing and cerebral MRI. Cognitive impairment no dementia (CIND) and dementia were diagnosed according to internationally accepted criteria. The prevalence of cognitive impairment and dementia were computed per 5 year age categories and gender. To examine the relationship between baseline associated factors and cognitive impairment, we used logistic regression models to compute odd ratios with 95% CI. RESULTS: 1538 Chinese subjects, aged ≥60 years, underwent cognitive screening: 171 (15.2%) were diagnosed with any cognitive impairment, of whom 84 were CIND mild, 80 CIND moderate and seven had dementia. The overall age adjusted prevalence of CIND mild was 7.2%; CIND moderate/dementia was 7.9%. The prevalence increased with age, from 5.9% in those aged 60-64 years to 31.3% in those aged 75-79 years and 44.1% in those aged ≥80 years. Multivariate analysis revealed age, diabetes and hyperlipidaemia to be independently associated with cognitive impairment. CONCLUSIONS: In present study, the overall prevalence of cognitive impairment and dementia in Chinese was 15.2%, which is in the same range as the prevalence reported in Caucasian and other Asian populations.
Authors: Ronald C Petersen; Oscar Lopez; Melissa J Armstrong; Thomas S D Getchius; Mary Ganguli; David Gloss; Gary S Gronseth; Daniel Marson; Tamara Pringsheim; Gregory S Day; Mark Sager; James Stevens; Alexander Rae-Grant Journal: Neurology Date: 2017-12-27 Impact factor: 9.910
Authors: Hieab H H Adams; Saima Hilal; Petra Schwingenschuh; Katharina Wittfeld; Sven J van der Lee; Charles DeCarli; Meike W Vernooij; Petra Katschnig-Winter; Mohamad Habes; Christopher Chen; Sudha Seshadri; Cornelia M van Duijn; M Kamran Ikram; Hans J Grabe; Reinhold Schmidt; M Arfan Ikram Journal: Alzheimers Dement (Amst) Date: 2015-10-31
Authors: Anthony N Kuo; Pavan K Verkicharla; Ryan P McNabb; Carol Y Cheung; Saima Hilal; Sina Farsiu; Christopher Chen; Tien Y Wong; M Kamran Ikram; Ching Y Cheng; Terri L Young; Seang M Saw; Joseph A Izatt Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799
Authors: Saima Hilal; Xu Xin; Seow Li Ang; Chuen Seng Tan; Narayanaswamy Venketasubramanian; Wiro J Niessen; Henri Vrooman; Tien Yin Wong; Christopher Chen; Mohammad Kamran Ikram Journal: Medicine (Baltimore) Date: 2015-06 Impact factor: 1.889
Authors: Saima Hilal; Yuek Ling Chai; Mohammad Kamran Ikram; Sakktivel Elangovan; Tan Boon Yeow; Xu Xin; Jun Yi Chong; Narayanaswamy Venketasubramanian; Arthur Mark Richards; Jenny P C Chong; Mitchell Kim Peng Lai; Christopher Chen Journal: Medicine (Baltimore) Date: 2015-01 Impact factor: 1.889